Trial Evaluating Lebrikizumab Plus TCS in Atopic Dermatitis Meets Endpoints
Treatment with lebrikizumab plus topical corticosteroids was associated with significant skin improvement in patients with moderate to severe atopic dermatitis.
Stay updated with breaking news from Eric Simpson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Treatment with lebrikizumab plus topical corticosteroids was associated with significant skin improvement in patients with moderate to severe atopic dermatitis.
/PRNewswire/ -- Lebrikizumab, an IL-13 inhibitor, significantly improved disease severity when combined with topical corticosteroids (TCS) in people with...
Lilly's lebrikizumab demonstrated significant skin improvement and itch relief when combined with topical corticosteroids in people with atopic dermatitis in third Phase 3 study - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- Lebrikizumab, an IL-13 inhibitor, significantly improved disease severity when combined with topical corticosteroids (TCS) in people with...
It may be Halloween, but thousands of people clad in costumes packed the RBCÂ Convention Centre this weekend for a different reason: Winnipeg Comiccon.